Proceedings of the Texas A&M Medical Student Grand Rounds

High Intensity Exercise and Depression: Therapeutic Implications through BDNF Upregulation

July 19, 2018 Vivy Phan

Vivy Phan

Introduction.  Major depressive disorder (MDD) is a world-wide health burden that severely affects a person’s mental health, specifically mood, consisting of persistent sadness or anhedonia leading to a constellation of cognitive and somatic symptoms that impacts a person’s daily life. The neurotropic hypothesis of depression proposes that changes in brain derived neurotrophic factor (BDNF) can affect the development and plasticity of neuronal connections. It has been shown that when exposed to stress, BDNF deficient mice have increased corticosterone levels, increased malodialdehyde (MDA) levels, and decreased catalase (CAT) antioxidant enzyme levels, alluding to a decreased ability to cope with stress1. Additionally, patients with MDD have low serum BDNF concentrations compared to healthy controls, therefore BDNF deficiency could be a target for depression therapy2. Exercise has been shown to increase serum BDNF in MDD patients3. When comparing various exercise regimens, HIIT training greatly increases BDNF in experimental rats over control rats without training and rats who underwent continuous training (CT)4. This suggests HIIT training could be  an effective therapy for MDD through the upregulation of BDNF and could be more beneficial than other types of training. Methods. Studies submitted rats to varying levels of exercise intensities via motorized treadmills and used immunoassays to measure various levels of neurotrophic factors, oxidative stress factors, and inflammatory mediators4,5,6. Exercise intensity was assessed through relationship with VO2 max values4,5,6. Results. In experimental mice, HIIT increased levels of hydrogen peroxide (H2O2) and TNF-a more in comparison to CT5. Another study showed that following 6 weeks of HIIT, experimental HIIT rats had elevated BDNF, reduced TNF, IL-6, IL1b, and IL10, increased SOD, and decreased TBARS4. High intensity exercise was associated with elevated proliferative cell density from P31 to P40, higher levels of IL6 from P21 to P30, and higher levels of BDNF, TNF-a, and IL106. Conclusions. Studies have found high intensity exercise to be associated with increased BDNF levels, reduced inflammatory mediators, and increased response to oxidative damage, over both control rats and continuous exercise rats. This suggests high intensity exercise as a potential treatment for MDD patients through its effect on BDNF.

 

  1. Hacioglu, Gulay, et al. “Assessment of Oxidative Stress Parameters of Brain-Derived Neurotrophic Factor Heterozygous Mice in Acute Stress Model.” Iran J Basic Med Sci, vol. 19, no. 4, 3 Mar. 2016, pp. 388–393.
  2. Molendijk, M. L., Spinhoven, P., Polak, M., Bus, B. A., Penninx, B. W. J. H., & Elzinga, B. M. (2014). Serum BDNF concentrations as peripheral manifestations of depression: Evidence from a systematic review and meta-analyses on 179 associations (N=9484). Molecular Psychiatry, 19,791–800.
  3. Kerling, A, et al. “Exercise increases serum brain-derived neurotrophic factor in patients with major depressive disorder.” Journal of affective disorders 215(2017):152-155. Web.
  4. Freitas, Daniel A., et al. “High Intensity Interval Training Modulates Hippocampal Oxidative Stress, BDNF and Inflammatory Mediators in Rats.” Physiology & Behavior, vol. 184, 2018, pp. 6–11.
  5. Afzalpour, Mohammad Esmaiel, et al. “Comparing Interval and Continuous Exercise Training Regimens on Neurotrophic Factors in Rat Brain.” Physiology & Behavior, vol. 147, 6 Apr. 2015, pp. 78–83.
  6. Almeida, Alexandre Aparecido De, et al. “Differential Effects of Exercise Intensities in Hippocampal BDNF, Inflammatory Cytokines and Cell Proliferation in Rats during the Postnatal Brain Development.” Neuroscience Letters, vol. 553, 8 Aug. 2013, pp. 1–6.

 

 

Neuroscience
Previous Post

IL-6 In Cytokine Release Syndrome during CAR-T Cell Therapy

Next Post

The Role of GM-CSF on Monocyte Polarization in Controlling the Regression of Malignant Melanoma

Scientific Editors

Steve A. Maxwell

Executive Editor
Tel: 979-436-0804
smaxwell@medicine.tamhsc.edu

Robin Fuchs-Young

Deputy Editor
Tel: 979-845-5109
fuchs-young@medicine.tamhsc.edu
Administrative Editor

Janis Chmiel

Tel: 979-436-0856
chmiel@medicine.tamhsc.edu
Editorial Office
Tel.: 979-845-2726
Fax: 979-847-9481
chmiel@medicine.tamhsc.edu
Archives
  • July 2026
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • May 2025
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • November 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • August 2022
  • June 2022
  • May 2022
  • August 2021
  • July 2021
  • April 2021
  • October 2020
  • August 2020
  • July 2020
  • August 2019
  • July 2019
  • February 2019
  • July 2018
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • January 2017
Proudly powered by WordPress | Theme: Fmi by Forrss.